People In The News

NEW YORK (GenomeWeb News) - Accelrys has named Max Carnecchia CEO, president, and a member of the board of directors, effective immediately. He replaces Todd Johnson, who resigned from his post on June 15 after serving as an interim CEO since January. Carnecchia had previously served as president of Interwoven, as VP of global sales at Xoriant, and VP of sales and services at SmartDB.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.